Loading...
OTCM
BIEL
Market cap3mUSD
Jul 18, Last price  
0.00USD
1D
0.00%
1Q
-33.33%
Jan 2017
-42.86%
IPO
-99.97%
Name

BioElectronics Corp

Chart & Performance

D1W1MN
OTCM:BIEL chart
No data to show
P/E
P/S
5.06
EPS
Div Yield, %
Shrs. gr., 5y
4.47%
Rev. gr., 5y
-7.33%
Revenues
715k
+1.03%
665,5101,289,8962,339,6462,089,6941,763,7651,045,873941,761829,5631,609,460707,412714,708
Net income
-723k
L-7.91%
-2,445,620-2,677,329-2,450,249-2,106,723-2,118,793-2,988,344-2,325,279-1,159,722-289,821-784,910-722,812
CFO
-336k
L-29.80%
00-1,719,709-1,307,641-868,908-1,352,414-715,683-528,037-320,299-478,601-335,991

Profile

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
IPO date
Apr 12, 2004
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
715
1.03%
707
-56.05%
Cost of revenue
521
454
Unusual Expense (Income)
NOPBT
194
254
NOPBT Margin
27.14%
35.85%
Operating Taxes
(168)
(228)
Tax Rate
NOPAT
362
482
Net income
(723)
-7.91%
(785)
170.83%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,302
1,898
Long-term debt
12,530
12,191
Deferred revenue
Other long-term liabilities
Net debt
14,827
14,044
Cash flow
Cash from operating activities
(336)
(479)
CAPEX
1
Cash from investing activities
Cash from financing activities
296
523
FCF
343
373
Balance
Cash
5
45
Long term investments
Excess cash
10
Stockholders' equity
(16,478)
7,580
Invested Capital
14,831
(1,676)
ROIC
5.50%
7.50%
ROCE
EV
Common stock shares outstanding
24,705,067
24,541,948
Price
0.00
-60.00%
0.00
-52.38%
Market cap
4,941
-59.73%
12,271
-51.82%
EV
19,768
26,315
EBITDA
194
254
EV/EBITDA
101.93
103.77
Interest
449
441
Interest/NOPBT
231.27%
174.08%